DarioHealth Corp. (DRIO) Return on equity 2017–2025
DarioHealth Corp. (DRIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-61.4%FY2025 · since FY2017: -399.5% → -61.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -61.4% | -2.1 pp |
| FY2024 | -59.4% | +42.9 pp |
| FY2023 | -102.2% | -24.5 pp |
| FY2022 | -77.7% | +12.0 pp |
| FY2021 | -89.7% | +14.9 pp |
| FY2020 | -104.6% | -10.7 pp |
| FY2019 | -93.9% | +105.6 pp |
| FY2018 | -199.5% | +200.0 pp |
| FY2017 | -399.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice